TCR2 Therapeutics Inc.

MUN:2K7 Lagerbericht

Marktkapitalisierung: €95.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

TCR2 Therapeutics Management

Management Kriterienprüfungen 3/4

TCR2 Therapeutics' CEO is Garry Menzel, appointed in Jan 2016, they has a tenure of 6.67 years. Their total yearly compensation is $1.90M , comprised of 30.4% salary and 69.6% bonuses, including company stock and options. They directly owns 0.69% of the company’s shares, worth €656.23K. The average tenure of the management team and the board of directors is 2 years and 3.1 years respectively.

Wichtige Informationen

Garry Menzel

Geschäftsführender

US$1.9m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts30.4%
Amtszeit als Geschäftsführer6.7yrs
Eigentum des Geschäftsführers0.7%
Durchschnittliche Amtszeit des Managements2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3.1yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Garry Menzel im Vergleich zu den Einnahmen von TCR2 Therapeutics verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2022n/an/a

-US$115m

Mar 31 2022n/an/a

-US$107m

Dec 31 2021US$2mUS$580k

-US$100m

Sep 30 2021n/an/a

-US$91m

Jun 30 2021n/an/a

-US$81m

Mar 31 2021n/an/a

-US$73m

Dec 31 2020US$6mUS$560k

-US$67m

Sep 30 2020n/an/a

-US$61m

Jun 30 2020n/an/a

-US$58m

Mar 31 2020n/an/a

-US$53m

Dec 31 2019US$8mUS$492k

-US$97m

Sep 30 2019n/an/a

-US$96m

Jun 30 2019n/an/a

-US$100m

Mar 31 2019n/an/a

-US$107m

Dec 31 2018US$3mUS$436k

-US$62m

Sep 30 2018n/an/a

-US$55m

Dec 31 2017US$792kUS$423k

-US$15m

Vergütung im Vergleich zum Markt: Garry's total compensation ($USD1.90M) is above average for companies of similar size in the German market ($USD410.59K).

Entschädigung vs. Einkommen: Garry's compensation has been consistent with company performance over the past year.

Geschäftsführer

Garry Menzel (58 yo)

6.7yrs

Amtszeit

US$1,904,534

Vergütung

Dr. Garry E. Menzel, Ph D., M.B.A. serves as an Independent Director at Black Diamond Therapeutics, Inc. since March 2017. He serves as Director at Stoke Therapeutics, Inc since August 17, 2020.He serves...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Garry Menzel
President6.7yrsUS$1.90m0.69%
$ 656.2k
Patrick Baeuerle
Founder & Member of the Advisory Boardno dataUS$47.02kkeine Daten
Peter Olagunju
Chief Technical Officer1.2yrsUS$2.74m0.0057%
$ 5.4k
Alfonso Cardama
Chief Medical Officer5.7yrsUS$1.04m0.12%
$ 116.0k
Richard Roomberg
Vice President of Corporate Controllerless than a yearkeine Datenkeine Daten
Eric Sullivan
Chief Financial Officerless than a yearkeine Datenkeine Daten
Carl Mauch
Senior Director of Investor Relations & Corporate Communicationsno datakeine Datenkeine Daten
Margaret Siegel
Head of Legal & Corporate Secretary4.7yrskeine Datenkeine Daten
Angela Justice
Chief People Officer2.9yrskeine Daten0.025%
$ 24.0k
Rosemary Harrison
Chief Business & Strategy Officerless than a yearkeine Datenkeine Daten

2.0yrs

Durchschnittliche Betriebszugehörigkeit

48yo

Durchschnittliches Alter

Erfahrenes Management: 2K7's management team is considered experienced (2 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Garry Menzel
President6.7yrsUS$1.90m0.69%
$ 656.2k
Patrick Baeuerle
Founder & Member of the Advisory Boardless than a yearUS$47.02kkeine Daten
Ansbert Gadicke
Independent Director7.3yrskeine Datenkeine Daten
Neil Gibson
Independent Director4.6yrsUS$92.52k0%
$ 0
Mitchell Finer
Chairman of Advisory Boardno dataUS$18.75kkeine Daten
Stephen Webster
Independent Chairman of the Board2.3yrsUS$89.08k0%
$ 0
Andrew Allen
Independent Director3.8yrsUS$86.58k0%
$ 0
Axel Hoos
Independent Director2.4yrsUS$78.08k0%
$ 0
Shawn Tomasello
Independent Director1.6yrsUS$405.41k0%
$ 0
Kai Wucherpfennig
Member of Advisory Boardno datakeine Datenkeine Daten
Stephan Grupp
Member of the Advisory Boardno datakeine Datenkeine Daten
Wolfgang Schamel
Member of Advisory Boardno datakeine Datenkeine Daten

3.1yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: 2K7's board of directors are considered experienced (3.1 years average tenure).